Today: 2 June 2026
Ondas Shares Edge Up on $110M Order Update—Risk Remains for Traders
2 June 2026
2 mins read

Ondas Shares Edge Up on $110M Order Update—Risk Remains for Traders

New York, June 1, 2026, 19:03 EDT

Ondas Inc. climbed Monday, finishing up 1.82% at $13.46. The move outpaced the Nasdaq as traders weighed the company’s fresh order update. Shares swung from $12.80 to $13.91 during a choppy session. After the bell, Google Finance listed Ondas at $13.41.

Order book front and center. Ondas said Friday it got over $30 million in orders during May, putting its second-quarter orders so far north of $110 million for its defense, security and autonomous tech platform. Backlog refers to contracted or ordered work not yet counted as sales.

Chairman and CEO Eric Brock said the order flow points to “continued execution” and better visibility for “future growth opportunities” in defense, homeland security and critical infrastructure. Oshri Lugassy, co-CEO at Ondas Autonomous Systems, said the market is shifting from standalone devices, and that the future isn’t “one drone, one robot or one sensor.” Ondas Inc.

Benzinga reported Monday that the orders include air defense, counter-UAS, loitering munitions, ISR systems, unmanned ground vehicles and robotic defense gear. Counter-UAS means tech to find, track or block drones, while ISR stands for intelligence, surveillance and reconnaissance.

Ondas started June aiming for a much higher revenue number than last year. First-quarter revenue came in at $50.1 million, well above the $4.3 million reported a year ago. The company also bumped up its 2026 revenue target to a minimum of $390 million. “Strong visibility into our 2026 targets,” Brock said. Ondas Inc.

Mixed picture for defense stocks. AeroVironment dropped 1.6%. Red Cat, a smaller drone and defense tech player, added 2.2%. Ondas’ move stood out, with its gain seeming to come from company news rather than a move across the drone sector.

Stocks ended higher. The S&P 500 rose 0.26% and the Nasdaq Composite gained 0.42%, helped by tech shares. Gains came as oil also climbed on U.S.-Iran tensions. “We don’t really know where things stand,” Thomas Martin, senior portfolio manager at GLOBALT, told Reuters about the talks. Reuters

Acquisition is another piece of the stock right now. Ondas said May 18 it plans to buy Omnisys Ltd., which makes AI-based battlefield optimization tools in Israel. Omnisys CEO Ofer Yarden said its BRO platform lets defense groups “optimize resources” and make faster calls. Ondas Inc.

But risks remain. Barron’s said after Ondas’ first-quarter report that the company was still nowhere near profitability, though losses were smaller than expected on an adjusted EBITDA basis — which excludes interest, tax, depreciation, amortization and some other items.

Share supply could also be an issue. On May 28, a prospectus supplement registered 2.7 million Omnisys-related shares for resale by selling stockholders. A same-day filing showed stockholders cleared an increase in authorized common shares to 1.2 billion. The resale registration doesn’t trigger direct selling right away, but it does mean more supply for the market to keep an eye on.

Ondas drew buyers on Monday as bulls looked at orders, a full backlog and its moves in defense autonomy. Bears point to big integration worries, more shares coming, and doubts that the business model will turn demand into steady profits. For now, investors sided with the bulls.

Stock Market Today

  • Cryosite (ASX:CTE) Shows Strong Earnings Per Share Growth and Revenue Increase
    June 1, 2026, 7:10 PM EDT. Cryosite (ASX:CTE) has delivered 20% compound annual growth in earnings per share (EPS) over the past three years, reflecting robust profitability in a market often dominated by loss-making tech stocks. The company's revenue rose 23% to AU$16 million, while EBIT margins remained stable, suggesting sustainable profit growth. With a market capitalization of AU$60 million, Cryosite's financial health is notable. Insider buying by Non-Executive Chairman Mark Kerr, who purchased shares worth AU$56,000, may signal confidence in the company's outlook. These factors make Cryosite attractive to investors seeking earnings growth and fiscal responsibility in a small-cap healthcare stock.

Latest articles

Ondas Shares Edge Up on $110M Order Update—Risk Remains for Traders

Ondas Shares Edge Up on $110M Order Update—Risk Remains for Traders

2 June 2026
New York, June 1, 2026, 19:03 EDT Ondas Inc. climbed Monday, finishing up 1.82% at $13.46. The move outpaced the Nasdaq as traders weighed the company’s fresh order update. Shares swung from $12.80 to $13.91 during a choppy session. After the bell, Google Finance listed Ondas at $13.41. Order book front and center. Ondas said Friday it got over $30 million in orders during May, putting its second-quarter orders so far north of $110 million for its defense, security and autonomous tech platform. Backlog refers to contracted or ordered work not yet counted as sales. Chairman and CEO Eric Brock
Nebius Stock Surges on Nvidia Approval—AI Cloud Stocks Push Higher

Nebius Stock Surges on Nvidia Approval—AI Cloud Stocks Push Higher

2 June 2026
Nebius surged 14.5% to $264.51 after Nvidia CEO Jensen Huang called it “growing incredibly fast” at Computex and Situational Awareness disclosed a 5.6% stake. Shares hit a 52-week high, trading over 24 million shares. Q1 revenue soared 684% to $399 million. Citigroup raised its price target to $287. Nebius will present at the BofA tech conference June 3.
Abivax Stock Sees Big After-Hours Moves After Trial Result

Abivax Stock Sees Big After-Hours Moves After Trial Result

2 June 2026
Abivax shares plunged 33.7% to $86.01 after hours on Nasdaq despite its ulcerative colitis drug obefazimod hitting the main goal in a 44-week Phase 3 trial. Both 25 mg and 50 mg doses showed over 50% clinical remission versus 10.4% for placebo. No new safety signals reported. Abivax plans a U.S. FDA filing late Q4 2026. Cash reserves stood at €491.6 million at March-end, funding into Q4 2027.
Nebius Stock Surges on Nvidia Approval—AI Cloud Stocks Push Higher
Previous Story

Nebius Stock Surges on Nvidia Approval—AI Cloud Stocks Push Higher

Go toTop